In this study, we revealed that PRDX2 inhibits the angiotensin II (Ang II)-induced formation of AAA by reducing oxidative stress and inflammatory responses in aortic lesions and preventing structural damage to the aorta. This evidence concerns the gene PRDX2 and triple-A syndrome.